On Demand Webinar

Decoding In Vitro Oncology Innovations: Organoids, OMICs, and Their Role in Early Drug Discovery and Clinical Applications

This popular GEN (Genetic Engineering & Biotechnology News) webinar explores the dynamic intersection of technology and biology, where in vitro tools and OMICs applications unravel mechanisms of action, drug discovery, and clinical translation.

Watch Now

What you will learn:

• Strengths and Weaknesses of In Vitro Tools: We discuss an array of in vitro tools including tumor cell lines, organoids, 3D cultures, high throughput screens (HTS), and their respective merits and limitations in the context of clinical translation.
  
  
• In Vitro Models for Biomarker Discovery: Here we delve into 2D and 3D models including cell lines and organoids. Our focus is on their utility in discovering biomarkers and signature responses, which are crucial for informed in vivo modeling and patient stratification in clinical settings.
  
  
• Application of OMICs in Early Drug Discovery: Together, we explore the role of OMICs applications, with a particular focus on tumor organoids and organoid screening in the early stages of drug discovery.

Dive into this transformative field with us and watch the webinar now.

Watch Now

About the Presenter:

Rajendra Kumari, PhD, Executive Director, Integrated Solutions, Crown Bioscience

As Executive Director of Integrated Solutions within the Commercial and Strategic Development team, Rajendra leads the focus of cross-disciplinary solutions for drug discovery and development. She has over 20 years of oncology research experience with a PhD in Molecular Pharmacology from the University of Leicester (UK). Prior to joining Crown Bioscience, Rajendra held post doctoral fellowships and Assistant Professor position in the Division of Preclinical Oncology within the Medical School, University of Nottingham where she developed in vitro and in vivo preclinical models including patient-derived systems and imaging capabilities. Rajendra also co-founded PRECOS Ltd in 2010, serving as COO and then following merger with Crown Bioscience, as CSO and General Manager for Crown Bioscience UK. In 2018, Rajendra became Global Head of Scientific Communications for all platforms at Crown Inc, working closely with multiple divisions and global departments to support the commercialization of R&D activity and capabilities. Rajendra is a member of the AACR and BACR and has authored over 40 abstracts and publications.